GHRH analog · albumin-bound.
CJC-1295 with DAC is a synthetic growth hormone-releasing hormone (GHRH) analog engineered for extended serum half-life via covalent albumin binding. The DAC (Drug Affinity Complex) modification is the distinguishing feature — it converts a short-acting peptide into a long-acting one. Supplied as research-grade material with 3rd-party HPLC verification and full Certificate of Analysis per lot.
CJC-1295 with DAC is a synthetic growth hormone-releasing hormone (GHRH) analog engineered for extended serum half-life via covalent albumin binding. The DAC (Drug Affinity Complex) modification is the distinguishing feature — it converts a short-acting peptide into a long-acting one.
CJC-1295 binds the GHRH receptor on anterior pituitary somatotrophs, stimulating pulsatile GH release in published preclinical studies. The DAC modification forms a covalent thioether bond with cysteine-34 of serum albumin within minutes of administration, protecting the peptide from renal clearance and DPP-4 degradation.
Published literature describes sustained elevations of GH and IGF-1 for up to 7 days following a single dose. The compound is not FDA-approved and is widely available as a research compound. CJC-1295 is on the WADA prohibited list (S2).
The above summarizes published research literature. This is not medical advice, a protocol, or a recommendation for use. This compound is supplied for laboratory research only.
CJC-1295 (w/DAC) is a 30-residue peptide with molecular formula C165H269N47O46 and molecular weight of approximately 3,647.3 Da.
The full structural data and release specifications are in the Compound Profile section above. Every lot ships with an independently verified Certificate of Analysis.
Each lot is independently verified by a 3rd-party analytical laboratory (STERIS Labs, Alcami Analytical, or equivalent) before release. Release specification is HPLC purity ≥ 99.5% (typical > 99.8%), mass spectrometry identity match within ±0.5 Da, water content < 5.0% Karl Fischer, and endotoxin < 0.25 EU/mL by LAL (USP <85>).
Look up the full COA for your lot at coa-lookup.html.
All compounds ship at ambient temperature in discreet, tamper-evident packaging. Lyophilized peptide powder is stable at room temperature for typical transit windows, which is why research-grade vendors ship this way. Tracked; signature not required.
Store unopened lyophilized product at 2–8°C protected from light. Once reconstituted, most peptides are stable at 2–8°C for approximately 28 days (compound-dependent).
Published literature describes sustained elevations of GH and IGF-1 for up to 7 days following a single dose. The compound is not FDA-approved and is widely available as a research compound. CJC-1295 is on the WADA prohibited list (S2).
All PeptideBros compounds are sold strictly as chemical reference materials for in-vitro laboratory research. They are not for human consumption.
HPLC-verified. Mass-spec confirmed. Ambient-stable transit. The paperwork other vendors hope you never ask for.